TWINSTRAND BIOSCIENCES INC
Ultra-rare variant detection with unparalleled sensitivity
Seattle, United States · Founded 2017 · $66.0M raised
- Headquarters
- Seattle, Washington
- Employees
- 11–50
- Founded
- 2017
- Business Model
- B2B
- Website
- twinstrandbio.com
- Total Funding
- $66.0M
- Last Round
- $50.0M Series BMay 2021
- Rounds
- 2
About
TwinStrand Biosciences develops and commercializes Duplex Sequencing technology, which improves DNA sequencing accuracy by over 10,000-fold to detect ultra-low frequency mutations invisible by conventional NGS methods. The company serves pharmaceutical companies, clinical research networks, academic centers, and regulatory agencies across applications including residual cancer detection, genetic toxicology, and mutagenesis assay testing.
Summary
TWINSTRAND BIOSCIENCES INC is a Biotech company based in Seattle, United States, founded in 2017. It has raised $66.0M in total across 2 rounds, most recently a $50.0M Series B round in May 2021. Investors include Madrona Venture, S32 and Soleus Capital.
Tech & App Stack
8 technologies & apps tracked
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
May 2021
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company
Specialty pharmaceutical company